Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
Clinical trial NCT04612894 · UNKNOWN
Trial details
- NCT number
- NCT04612894
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2022-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.